Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7
2 clinical trials · Condition
◉ Watch Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7
| Record | Firm | Date |
|---|---|---|
| ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment (NCT02917629) | National Cancer Institute (NCI) | 2018-05-31 |
| Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell Cancer (NCT03144778) | M.D. Anderson Cancer Center | 2017-07-12 |
Track Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 automatically
Every clearance here is in the API, with alerts when new ones post.